A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis
Clinical trial NCT01634087 · COMPLETED
Trial details
- NCT number
- NCT01634087
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.